YAKUGAKU ZASSHI
Online ISSN : 1347-5231
Print ISSN : 0031-6903
ISSN-L : 0031-6903
誌上シンポジウム
医薬品医療機器総合機構(PMDA)で新たに開始した薬事戦略相談事業について
益山 光一
著者情報
ジャーナル フリー

2013 年 133 巻 2 号 p. 183-186

詳細
抄録

  Universities, research institutions, and venture capitals that possess promising “seed” research or technologies in Japan, are not always familiar with development strategies that lead to commercialization of the products in spite of their excellent science and research. In order to create innovative pharmaceuticals and medical devices originating from Japan, Pharmaceuticals and Medical Devices Agency (PMDA) launched new scientific consultation service, named ‘Pharmaceutical Affairs Consultation on R&D Strategy’ for universities, research institutions, and venture capitals on July 1, 2011. Through these consultations, the guidance and advice on the tests needed in the early development stage and the necessary clinical trials would be provided toward commercialization.

著者関連情報
© 2013 by the PHARMACEUTICAL SOCIETY OF JAPAN
前の記事 次の記事
feedback
Top